Clinical study of Shenqi Fuzheng injection decreasing side-effects of chemotherapy for patients with ovarian epithelial cancer

By Zhang Yu   Wan Jing   Yang Yuebo   Li Xiaomao  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 537-539

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer

By Kim Hye Jin   Lee Keun-wook   Kim Yu Jung   Oh Do-youn   Kim Jee Hyun   Im Seock-ah   Lee Jong Seok  

Acta Oncologica, Vol. 48, Iss. 3, 2009-04 ,pp. : 385-390

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1295-1300

Science Publishers

Access to resources Recommend Favorite

Tropisetron, Ondansetron, and Granisetron for Control of Chemotherapy-Induced Emesis in Turkish Cancer Patients: A Comparison of Efficacy, Side-Effect Profile, and Cost

By Abali Huseyin   Celik Ismail  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 135-139

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

By Rossi Luigi   Veltri Enzo   Zullo Angelo   Zoratto Federica   Colonna Maria   Di Seri Marisa   Longo Flavia   Mottolese Marcella   Giannarelli Diana   Ruco Luigi   Romiti Adriana   Barucca Viola   Adua Daniela   Tomao Silverio  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1193-1197

Future Medicine

Access to resources Recommend Favorite